Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2013, Article ID 897434, 7 pages
Research Article

Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy

1Division of Nephrology and Hypertension, Department of Internal Medicine, East Carolina University, Greenville, NC 27858, USA
2Department of Global Health Economics and Outcomes Research, Xcenda, LLC, Palm Harbor, FL 34685, USA
3Department of Medical Affairs, Novartis Pharmaceuticals Corporation, East Hanover NJ 07936, USA

Received 25 June 2012; Accepted 7 December 2012

Academic Editor: Gaetano Ciancio

Copyright © 2013 K. Parker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

The Myfortic Transplant Coordinator Survey was a four-part electronic web-based survey which was sent to transplant coordinators in the US. The first section requested information on the respondent’s demographics, including their experience and role, and the number of transplants performed at their center. The second section comprised seven questions about patient confusion regarding immunosuppressive medication, such as how frequently patients asked questions about their therapy, the number of telephone calls the respondent answered per day relating to immunosuppressive therapy, and their assessment of patient confusion levels. The third section of the survey focused on the impact on the respondent’s workload, in terms of time required to answer questions about immunosuppressive medication, whether this workload had changed in recent years, what factors influenced the amount of patient education required, and whether introduction of generic immunosuppressant medications had affected workload. The final section comprised nine questions concerning interruptions or changes to immunosuppressive therapy, and the use of generic preparations. Questions primarily offered multiple-choice answers, with a small number requesting free text responses.

  1. Supplementary Material